Avidity Biosciences, Inc.
RNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $4 | $4 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $3 | $4 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 224.3% | 144.6% | -47.1% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 100% | -3,490.5% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,389.9% | -4,427.6% | -8,311% | -4,044.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,398.3% | -4,089.3% | -7,360% | -3,439.5% |
| EPS Diluted | -1.27 | -1.21 | -0.9 | -0.8 |
| % Growth | -5% | -34.4% | -12.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |